Clinical Trial

Evaluation of VEDAN RT-90 Resistant Cassava Starch for Glycemic Control and Prebiotic Fiber Development in a Human Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate the effects of RT-90 resistant cassava starch on glycemic control using a human dietary trial and to evaluate its potential as a prebiotic fiber supplement. This study will assess the efficacy of RT-90 resistant cassava starch in improving glycemic control, body composition, and gut microbiome in healthy individuals.
Trial Details
NCT Number NCT07282496
Lead Sponsor Chung Shan Medical University
Conditions Resistant Starch, Tapioca Starch, Prebiotic Fiber, Blood Sugar
Enrollment 115 participants
Start Date 2025-12-20
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-15